Company Filing History:
Years Active: 1988-1991
Title: Takaharu Ono: Innovator in Pharmaceutical Advancements
Introduction
Takaharu Ono is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that improve venous extensibility and suppress cardiac hypertrophy. With a total of 3 patents to his name, Ono's work is recognized for its potential impact on medical treatments.
Latest Patents
Ono's latest patents include innovative compounds aimed at addressing critical health issues. One of his notable inventions is a venous extensibility improving and cardiac hypertrophy suppressant agent, which involves dihydropyridine compounds. These compounds are designed to enhance venous extensibility and mitigate cardiac hypertrophy. Another significant patent is a diuretic or antihypertensive composition, which outlines a method for treating edema or hypertension using a quinazoline derivative. This method involves administering an effective amount of the compound to individuals in need of treatment.
Career Highlights
Takaharu Ono is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to improving patient outcomes through scientific advancements.
Collaborations
Ono has collaborated with esteemed colleagues, including Mitsuyoshi Nakashima and Mitsutaka Kanamaru. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Takaharu Ono's contributions to the field of pharmaceuticals exemplify the importance of innovation in medical science. His patents reflect a dedication to improving health outcomes and advancing treatment options for patients.